| Line Item | 2024-05-31 | Y/Y |
|---|---|---|
| Revenue | $52.96B | +6.0% |
| R&D Expense | $8.91B | +3.4% |
| SG&A Expense | $1.55B | -2.0% |
| Operating Income | $15.35B | +17.3% |
| Interest Expense | $3.51B | +0.3% |
| Income Tax | $1.27B | +104.5% |
| Net Income | $10.47B | +23.1% |
| EPS (Basic) | $3.82 | +21.3% |
| EPS (Diluted) | $3.71 |
| Line Item | 2024-05-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $10.45B | +7.1% |
| Accounts Receivable | $7.87B | +13.9% |
| Inventory | $334.0M | +12.1% |
| Current Assets | $22.55B | +7.4% |
| Total Assets | $140.98B | +4.9% |
| Current Liabilities | $31.54B | +36.6% |
| Stockholders' Equity | $8.70B | +711.2% |
| Line Item | 2024-05-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $18.67B | +8.8% |
| Capital Expenditures | $6.87B | -21.0% |
| Investing Cash Flow | -$7.36B | +79.8% |
| Financing Cash Flow | -$10.55B | -233.4% |
| Free Cash Flow | $11.81B | +39.4% |
| +20.8% |